| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/25/2005 | WO2005042481A3 COMPOUNDS AND RELATED METHODS FOR MUTANT p53 REACTIVATION |
| 08/25/2005 | WO2005037868A3 Methods of treating nfat-related disorders |
| 08/25/2005 | WO2005034999A3 Composition comprising association complex of a pharmaceutical and a poloxamer |
| 08/25/2005 | WO2005030109A9 Regimen for the administration of rifamycin-class antibiotics |
| 08/25/2005 | WO2005023818A3 Heterobicyclic compounds as pharmaceutically active agents |
| 08/25/2005 | WO2005021584A3 Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus |
| 08/25/2005 | WO2005021515A3 Inhibitors of phosphodiesterase type-iv |
| 08/25/2005 | WO2005020982A3 Using selective antagonists of persistent sodium current to treat neurological disorders and pain |
| 08/25/2005 | WO2005020929A3 Sustained release dosage forms of ziprasidone |
| 08/25/2005 | WO2005016306A3 Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation |
| 08/25/2005 | WO2005011601A3 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 08/25/2005 | WO2005010154A3 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/25/2005 | WO2005000850A3 Novel crystalline forms of valacyclovir hydrochloride |
| 08/25/2005 | WO2004108687A3 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection |
| 08/25/2005 | WO2004106493A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 08/25/2005 | WO2004074450A3 Combination therapy for treating protein deficiencies |
| 08/25/2005 | WO2004066982A8 Stable oral benzimidazole compositions and processes for their preparation |
| 08/25/2005 | WO2004064844A9 Method for inhibition of necrosis induced by neurotrophin |
| 08/25/2005 | WO2003098385A3 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 08/25/2005 | US20050187409 Inhibitors of RNase P proteins as antibacterial compounds |
| 08/25/2005 | US20050187389 Pyrrolo[2,3-d]pyrimidine derivatives; inhibitors of protein tyrosine kinase activity especially modulators of epidermal growth factor receptor; antiproliferative; anticancer; blood vessel growth, benign hyperplasia, keloid formation, psoriasis; (1-Phenylethyl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine |
| 08/25/2005 | US20050187304 drugs generated from combinatorial libraries of compounds based on scaffold structures that can form non-covalent complexes with the soluble forms of amyloid proteins; drugs capable of breaking the beta-sheet conformation in amyloid proteins |
| 08/25/2005 | US20050187303 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 08/25/2005 | US20050187302 administering the selective estrogen receptor modulator ospemifene, 2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol |
| 08/25/2005 | US20050187301 granulates containing 2-[4-[(Z)-4-chloro-1,2-di(phenyl)but-1-enyl]phenoxy]ethanol, isomers, stereoisomers, salts or metabolites, in combination with excipients, having inproved solubility; dosage form of existing drug; selective estrogen receptor modulators |
| 08/25/2005 | US20050187300 pro-apoptotic compounds; e.g. tumors, autoimmune diseases, viral infection, psoriasis; N-(substituted phenyl)-2-hydroxybenzamides e.g. 5-Chloro-2-hydroxy-N-(4-((2-methoxyethyl)-methylamino)-2-(2-(3-trifluoromethylphenyl)ethoxy)phenyl)benzamide |
| 08/25/2005 | US20050187299 2-(1-hydroxyalkyl)-cyclopent-2-en-1-one derivative starting material is thermally rearranged to a 2-alkylidene-3-oxo-cyclopentylacetate derivative; intermediates to perfumes such as methyl jasmonate |
| 08/25/2005 | US20050187298 preferebtial inhibitors of cytochrome P-450 monooxygenase enzyme system, administered for treatment of skin, autoimmune, inflammatory, proliferative, nervous system, vision and respiratory system disorders |
| 08/25/2005 | US20050187297 New compounds, methods for their preparation and use thereof |
| 08/25/2005 | US20050187295 Processes for the preparation of gabapentin |
| 08/25/2005 | US20050187294 With lipoxin analog inhibitors of polyisoprenyl phosphate signaling; treating diseases associated with phospholipase D (PLD) initiated polymorphoneutrophil (PMN) inflammation |
| 08/25/2005 | US20050187293 Administering an ester of methionine or methionine amide and/or an ester of the hydroxy analogue of methionine; provides increased protein and fat content in the milk; improved fertility, liver function and an increase in energy |
| 08/25/2005 | US20050187292 Hyperlipemia therapeutic agent |
| 08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction |
| 08/25/2005 | US20050187290 administering vitamin C or derivatives, as cyclic adenosine monophosphate (cAMP) modulators; demyelination; Charcot-Marie-Tooth disease; genetic disorders |
| 08/25/2005 | US20050187288 administering antiproliferative agents comprising 3,4-dihydro-2,2-dimethyl-2H-naphtho [1,2-b]pyran-5,6-dione, derivatives, analogs or metabolites and carriers |
| 08/25/2005 | US20050187287 Improved tubulin polymerization |
| 08/25/2005 | US20050187286 Cytotoxin Compound and Method of Isolation |
| 08/25/2005 | US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases |
| 08/25/2005 | US20050187284 Integrin receptor inhibitors |
| 08/25/2005 | US20050187283 Administering a safe and effective amount of a dopamine agonist, in particular, ropinirole, to a patient suffering from anoxic and hypoxic brain injuries |
| 08/25/2005 | US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 08/25/2005 | US20050187280 Furosemide modulators of HM74 |
| 08/25/2005 | US20050187278 combination therapy comprised of a cAMP-specific PDE inhibitors and a cyclooxygenase-2 selective inhibitor; cardiovascular disorders |
| 08/25/2005 | US20050187277 Protein tyrosine phosphatase inhibitors; diseases including type I and type II diabetes, cancer, autoimmune diseases, AIDS; imidazole, oxazole and thiazole derivatives; e.g. 4-(4-(2,4-dichloro-phenyl)-2-(2-(3'-methanesulfonyl-biphenyl-4-yl)-(E)-vinyl)-imidazol-1-ylmethyl)-benzoic acid |
| 08/25/2005 | US20050187276 Compounds, compositions and methods |
| 08/25/2005 | US20050187275 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide |
| 08/25/2005 | US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 08/25/2005 | US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation |
| 08/25/2005 | US20050187271 and for reducing undesirable side effects of antitumor agents |
| 08/25/2005 | US20050187270 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
| 08/25/2005 | US20050187269 Benzimidazole derivative and use thereof |
| 08/25/2005 | US20050187268 Non-peptidyl agents with pHSP20-like activity, and uses thereof |
| 08/25/2005 | US20050187267 Nonsteroidal, nontoxic tissue selective modulators for side effect reduction; age-related and androgen-receptor related conditions such as sarcopenia; e.g. 4-(4-Hydroxy-1,1,3-trioxohexahydrothia-2,6a-diazapentalen-2-yl)-2-chloro-3-methylbenzonitrile |
| 08/25/2005 | US20050187265 Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 08/25/2005 | US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints |
| 08/25/2005 | US20050187263 Oxydecahydronaphthalene modulators of HM74 |
| 08/25/2005 | US20050187262 Treating a cardiovascular disorder by administering a low dosage of enantiomerically pure (S)-amlodipine along with an angiotensin receptor blocker from the group of candesartan, eprosartan, telmisartan, irbesartan, pratosartan, valsartan or olmesartan; side effect reduction; hypotensive agents; angina |
| 08/25/2005 | US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine |
| 08/25/2005 | US20050187260 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazole compounds and their use as anti-depressants |
| 08/25/2005 | US20050187259 Imidazoline derivatives having CB1-antagonistic activity |
| 08/25/2005 | US20050187257 Methods of treating sepsis |
| 08/25/2005 | US20050187256 New compounds useful for the synthesis of S- and R-omeprazole and a process for their preparation |
| 08/25/2005 | US20050187255 Novel curcumin analogues and uses thereof |
| 08/25/2005 | US20050187254 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
| 08/25/2005 | US20050187253 Medicinal kit to quit tobacco consumption comprising central cannabinoid receptor antagonist |
| 08/25/2005 | US20050187252 Novel compounds as opioid receptor modulators |
| 08/25/2005 | US20050187251 Substituted N-heterocycle derivatives and methods of their use |
| 08/25/2005 | US20050187250 Method of correcting HERG channel dysfunction |
| 08/25/2005 | US20050187249 Lypohilization product |
| 08/25/2005 | US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5) |
| 08/25/2005 | US20050187245 Stable amorphous forms of montelukast sodium |
| 08/25/2005 | US20050187244 Montelukast sodium polymorphs |
| 08/25/2005 | US20050187243 Montelukast free acid polymorphs |
| 08/25/2005 | US20050187242 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases |
| 08/25/2005 | US20050187241 Method of inhibiting choroidal neovascularization |
| 08/25/2005 | US20050187240 Derivatives as antitumor, anticarcinogenic agents and microbiocides; conversion of isoaaptamine which is relatively unstable to its novel and more stable sodium phosphate prodrug, hystatin 1; conversion of aaptamine to numerous compounds including 9-demethyloxyaaptamine and 4-methylaaptamine |
| 08/25/2005 | US20050187239 Synergistic l-methadone compositions and methods of use thereof |
| 08/25/2005 | US20050187237 Therapeutic compounds and uses thereof |
| 08/25/2005 | US20050187236 Nitrogen-containing aromatic derivatives |
| 08/25/2005 | US20050187235 Pyrimidine derivatives useful as selective COX-2 inhibitors |
| 08/25/2005 | US20050187234 Reference standard for characterization of rosuvastatin |
| 08/25/2005 | US20050187233 JAK-3 inhibitors for treating allergic disorders |
| 08/25/2005 | US20050187231 4-aminoquinazolines e.g. 4-(4-phenylbutylamino)quinazoline; antiproliferative agents; antitumor agents; hyperproliferative disorders, including tumors, such as breast, brain, and kidney tumors |
| 08/25/2005 | US20050187230 Compounds and compositions as protein kinase inhibitors |
| 08/25/2005 | US20050187229 Crystalline forms of valacyclovir hydrochloride |
| 08/25/2005 | US20050187228 Derivatives of purine, their preparation process and pharmaceutical compositions containing them |
| 08/25/2005 | US20050187227 8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition |
| 08/25/2005 | US20050187226 A1 adenosine receptor antagonists |
| 08/25/2005 | US20050187225 dissolving in solvent; precipitation; isolation; sleep disorders; sedatives; antiepileptic agents |
| 08/25/2005 | US20050187223 Antiinflammatory agents; rheumatic diseases;Paget's disease; leukemia; inflammatory bowel disorders; adult respiratory distress syndrome; antiallergens; Alzheimer's disease;% |
| 08/25/2005 | US20050187221 Method of treating ischemia reperfusion injury |
| 08/25/2005 | US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis |
| 08/25/2005 | US20050187219 Pyrazolotriazines as kinase inhibitors |
| 08/25/2005 | US20050187218 Imidazole based kinase inhibitors |
| 08/25/2005 | US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines |
| 08/25/2005 | US20050187216 Administering an effective amount of a proton pump inhibitor to the mammal for prevention of gastric ulcers in a mammals |
| 08/25/2005 | US20050187215 synergistic mixture of certain previously disclosed cyclic ketoenols and agonists or antagonists of nicotinic acetylcholine receptors |
| 08/25/2005 | US20050187213 A ready-to-use two-component pharmaceutical comprising meloxicam or a pharmaceutically salt and a pharmaceutically carrier and an antibiotic of beta -lactams, quinolones, tetracyclines, sulfonamides, fenicoles, and/or macrolides and a pharmaceutically carrier; veterinary medicine. |
| 08/25/2005 | US20050187212 Pharmaceutical composition for topical delivery of meloxicam |